TCL Archive Historical Vs. Current Controls: Comparability, Ethical Issues Argued By Moertel, Freireich April 20, 1979
TCL Archive Bad News for EPO Products Brings FDA Scrutiny, Payment Curbs. FDA Issues Alert to Doctors. February 23, 2007
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive In Brief: ACCC Lobbyists Got What They Wanted In House Cancer Act Bill; VA Group Review Set May 2 April 28, 1978
